GF
GRAF FINCKENSTEIN FRIEDRICH
Directeur Médical
OtherM
Insider track record
ExecutiveAcross 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by GRAF FINCKENSTEIN FRIEDRICH, Directeur Médical. Officer active across 1 company, notably Iovance Biotherapeutics, INC.. Aggregated, 18 disclosures have been published. History available since 14 June 2022. The latest transaction was filed on 5 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations18 total
7,813 shares0Common StockSEC:0001104659-26-071897:0
3,976 shares@ US$4.230.0008% mcap100.0% of flowCommon StockSEC:0001104659-26-071897:1
62,497 shares0Common StockSEC:0001104659-25-021055:0
2,813 shares0Common StockSEC:0001104659-25-004204:0
3,906 shares0Common StockSEC:0001104659-24-125542:0
2,813 shares0Common StockSEC:0001104659-24-109277:0
3,907 shares0Common StockSEC:0001104659-24-097490:0
2,813 shares0Common StockSEC:0001104659-24-080617:0
3,906 shares0Common StockSEC:0001104659-24-068773:0
2,812 shares0Common StockSEC:0001104659-24-048428:0
15,623 shares0Common StockSEC:0001104659-24-031578:0
2,813 shares0Common StockSEC:0001104659-24-004865:0
2,813 shares0Common StockSEC:0001104659-23-109940:0
2,813 shares0Common StockSEC:0001104659-23-081714:0
2,812 shares0Common StockSEC:0001104659-23-046843:0
11,248 shares0Common StockSEC:0001104659-23-005048:0
19,690 shares0Common StockSEC:0001104659-23-001607:0
19,690 shares0Common StockSEC:0001104659-22-071967:0
About GRAF FINCKENSTEIN FRIEDRICH
Friedrich Graf Finckenstein serves as Chief Medical Officer at IOVANCE BIOTHERAPEUTICS, INC. In this role, he is responsible for overseeing the medical and clinical aspects of the company's operations. Friedrich brings his expertise to guide product development and ensure compliance with regulatory standards. His leadership is essential for innovation and continuous improvement in the healthcare solutions provided by the company.